● Chloramphenicol is a broad-spectrum antibiotic with bacteriostatic activity against many Gram-positive and Gram-negative bacteria; it is n
● Chloramphenicol is a broad-spectrum antibiotic with bacteriostatic activity against many Gram-positive and Gram-negative bacteria; it is not effective against fungi, protozoa or viruses [1]
● It acts by binding to bacterial ribosomes and inhibiting protein synthesis at an early stage [1]
● Mainly bacteriostatic, but bactericidal against some Gram-positive cocci, Haemophilus influenzae and Neisseria; the spectrum also includes rickettsiae and chlamydia [2]
● Recognised conjunctival pathogens that may be susceptible: Staphylococcus aureus, Streptococcus pyogenes, Streptococcus pneumoniae, other beta-haemolytic streptococci, Haemophilus influenzae, Moraxella catarrhalis and Neisseria gonorrhoeae; acquired resistance has been described in all of these species, and chloramphenicol is not generally active against enterobacteriaceae or non-fermenters such as Pseudomonas aeruginosa [1]
● Clear, colourless to slightly yellow sterile eye drops, chloramphenicol 0.5% w/v (5 mg/mL), in 0.4 mL single-dose units [1][2]
| Product Name | Chloramphenicol Eye Drops 0.5% (5 mg/mL) 0.4 mL |
|---|---|
| Dosage Form | Ophthalmic |
| Strength | 0.5% (5 mg/mL) 0.4 mL |
| Standards | BP / ENTERPRISE |
| Packing | Customized per market requirement (bottle / blister / box) |
| Documents | COA, COPP, DMF, CTD Dossiers |
| MOQ | Contact us for MOQ and current stock |
Reference information summarised from WHO prescribing guidance. Expand each item below — clinical use must always follow the locally approved product insert.
Reference: WHO Model Formulary / WHO Model List of Essential Medicines. For professional reference only — clinical use must follow the locally approved product insert and national treatment guidelines.
Full batch testing and quality traceability under standard GMP workshops.
Sufficient stock on regular items, familiar with export logistics to 50+ countries.
COA, DMF, dossier and legalization documents for your market registration.
Every batch of Chloramphenicol Eye Drops 0.5% (5 mg/mL) 0.4 mL ships with a Certificate of Analysis (COA). For market registration we provide COPP, DMF and CTD-format dossiers, plus legalisation support where your authority requires it.
MOQ and lead time for Chloramphenicol Eye Drops 0.5% (5 mg/mL) 0.4 mL depend on strength, packaging and destination market. Send us your target market and annual volume — our export team confirms current stock, MOQ and lead time within 24 hours.
Yes. We offer OEM packaging and private-label production for Chloramphenicol Eye Drops 0.5% (5 mg/mL) 0.4 mL, subject to the regulatory requirements of the destination market.
We have supplied ophthalmic products to 50+ countries across Africa, Southeast Asia, Latin America and the Middle East, with experience in ministry-of-health registration and international tenders.
Chloramphenicol Eye Drops 0.5% (5 mg/mL) 0.4 mL is produced in China-GMP workshops (site re-inspected and passed in 2026), released only after full QC testing against BP / enterprise standards, with retained samples kept for one year beyond the product's expiry date.